Literature DB >> 16155372

Preparation and biological characteristics of recombinant human bone morphogenetic protein-2-loaded dextran-co-gelatin hydrogel microspheres, in vitro and in vivo studies.

Faming Chen1, Zhifen Wu, Qintao Wang, Hong Wu, Yongjie Zhang, Xin Nie, Yan Jin.   

Abstract

Hydrogels are based on hydrophilic polymers which are cross-linked to prevent dissolution in water. Because hydrogels can contain large amounts of water, they are interesting devices for the delivery of protein drugs. In this contribution, biodegradable dextran-co-gelatin hydrogel microspheres (DG-MPs) are described which are based on physical interactions and are particularly suitable for the controlled delivery of pharmaceutically active proteins. The unique feature of this preparation system is that the hydrogel microsphere formation takes place in an all-aqueous solution, by which the use of organic solvents is avoided. We investigated the preparation and biological activities of recombinant human bone morphogenetic protein-2 (rhBMP2)-loaded dextran-co-gelatin hydrogel microspheres (rhBMP2-DG-MPs), which aimed to keep rhBMP2's biological activity and to achieve a long-term sustained release of rhBMP2. The microspheres' average diameter was about 20-40 microm and rhBMP2 release in vitro could be maintained for >10 days. Cytology studies showed that using rhBMP2-DG-MPs could promote the proliferation and osteoblastic differentiation of periodontal ligament cells better than using rhBMP2 aqueous solution. By a freeze-drying method, rhBMP2-DG-MPs could be adhered in chitosan membranes for guided tissue regeneration use, namely functionalized membranes. To evaluate bone regeneration induced by rhBMP2-DG-MPs, an animal experiment with canine class III furcation defects was adopted and the results indicated that using rhBMP2-DG-MPs incorporating scaffolds and functionalized membranes could gain more periodontal tissue regeneration than using scaffolds and general membranes soaked with concentrated rhBMP2 aqueous solution. Therefore, those studies demonstrate the potential of DG-MPs in the sustained delivery of low dosages of rhBMP2 to periodontal defects. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155372     DOI: 10.1159/000088212

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  7 in total

Review 1.  Inductive tissue engineering with protein and DNA-releasing scaffolds.

Authors:  David M Salvay; Lonnie D Shea
Journal:  Mol Biosyst       Date:  2005-11-25

2.  Recent Advances of Pullulan and/or Dextran-Based Materials for Bone Tissue Engineering Strategies in Preclinical Studies: A Systematic Review.

Authors:  Naïma Ahmed Omar; Joëlle Amédée; Didier Letourneur; Jean-Christophe Fricain; Mathilde Fenelon
Journal:  Front Bioeng Biotechnol       Date:  2022-06-30

3.  Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery.

Authors:  Fa-ming Chen; Zhi-wei Ma; Guang-ying Dong; Zhi-fen Wu
Journal:  Acta Pharmacol Sin       Date:  2009-03-23       Impact factor: 6.150

4.  The Application of Microencapsulation Techniques in the Treatment of Endodontic and Periodontal Diseases.

Authors:  Asteria Luzardo Alvarez; Francisco Otero Espinar; José Blanco Méndez
Journal:  Pharmaceutics       Date:  2011-08-26       Impact factor: 6.321

Review 5.  Bone Regeneration Using Bone Morphogenetic Proteins and Various Biomaterial Carriers.

Authors:  Zeeshan Sheikh; Mohammad Ahmad Javaid; Nader Hamdan; Raheel Hashmi
Journal:  Materials (Basel)       Date:  2015-04-15       Impact factor: 3.623

Review 6.  Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration.

Authors:  Inas El Bialy; Wim Jiskoot; M Reza Nejadnik
Journal:  Pharm Res       Date:  2017-03-24       Impact factor: 4.200

Review 7.  Preparation and drug delivery of dextran-drug complex.

Authors:  Shiyu Huang; Gangliang Huang
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.